Scientist Earns Lifetime Achievement Award for Genetic Research
UC News Wire
Dr. Richard Gatti, professor of pathology and laboratory medicine at UCLA’s David Geffen School of Medicine, received a lifetime achievement award from the A-T (Ataxia-Telangiectasia) Medical Research Foundation on Oct. 23.
Gatti, of Sherman Oaks, Calif., was recognized for his pioneering efforts in cloning the A-T gene and his continued progress in researching new therapies for the genetic disorder. Gatti’s laboratory performs prenatal testing for A-T and is the world leader in confirming suspected diagnoses of the disease.
Ataxia-Telangiectasia is a progressively degenerative, life-shortening neurological and immunological disease that strikes children before the age of 3, causing a severe loss of balance. By the age of 10, most children with A-T are confined to a wheelchair.
The gene that causes A-T is also a cancer gene, and one in three children with the disease develop lymphoma or leukemia. Carriers of the gene are eight times more likely to develop cancer than the general population.
Copyright©1999-2001 edu-fair.com All